Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Tosylate and Propofol for Upper GI Endoscopy Sedation
NCT05876793Completed
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Jun 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of remimazolam, sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Incidence of body movements or coughing at Day 1. Started Jun 2023; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05876793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05876793.